Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Relypsa Inc (NASDAQ:RLYP)

17.29
Delayed Data
As of Feb 08
 -0.78 / -4.32%
Today’s Change
10.26
Today|||52-Week Range
42.26
-38.99%
Year-to-Date

Today’s Trading

Previous close18.07
Today’s open17.85
Day’s range16.85 - 17.94
Volume2,220,713
Average volume (3 months)2,463,953
Market cap$753.4M
Dividend yield--
Data as of 4:00pm ET, 02/08/2016

Growth & Valuation

Earnings growth (last year)+10.99%
Earnings growth (this year)-79.94%
Earnings growth (next 5 years)+21.09%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.35

Competitors

 Today’s
change
Today’s
% change
PACBPacific Biosciences ...-0.20-2.17%
MNTAMomenta Pharmaceutic...-0.77-6.54%
IMGNImmunoGen Inc-0.52-6.81%
AIMTAimmune Therapeutics...-1.05-6.73%
Data as of 4:00pm ET, 02/08/2016

Financials

Next reporting dateMarch 9, 2016
EPS forecast (this quarter)-$1.35
Annual revenue (last year)$0.00
Annual profit (last year)-$79.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John A. Orwin
Chief Financial Officer &
Senior Vice President
Kristine McClintock Ball
Corporate headquarters
Redwood City, California

Forecasts

Partner Offers